Keyphrases
Tumor Necrosis Factor-α
100%
Interleukin-17 (IL-17)
100%
Intestinal mucosal Inflammation
100%
MicroRNA-301a
100%
CD4+ T Cells
18%
Mucosa
18%
Peripheral Blood Mononuclear Cells
18%
Th17 Cell Differentiation
18%
Anti-microRNA
18%
SNIP1
18%
Lentivirus
12%
Antisense microRNA
12%
Autoimmune Disease
6%
Inflammatory Cytokines
6%
Novel Mechanism
6%
Knockdown
6%
Novel Therapeutics
6%
Quantitative PCR
6%
Colon
6%
Cell Tumor
6%
Peripheral Blood
6%
Colitis
6%
Healthy Controls
6%
Acid Activation
6%
Anti-tumor Necrosis Factor (anti-TNF)
6%
Infliximab
6%
Trinitrobenzene Sulfonic Acid
6%
Pre-miR
6%
Pre-microRNA
6%
Functional Target
6%
Tumourigenesis
6%
2,4,6-trinitrobenzene Sulfonic Acid (TNBS)-induced Colitis
6%
MiR-301a-3p
6%
Reverse Complementary Sequence
6%
Mouse Colitis
6%
Immunology and Microbiology
Tumor Necrosis Factor Alpha
100%
Inflammatory Bowel Disease
100%
Interleukin 17
100%
T-Helper Cell
37%
Mucosa
37%
Th17 Cell
37%
Cell Differentiation
37%
Colitis
37%
Peripheral Blood Mononuclear Cell
37%
Antisense
25%
Lentivirus
25%
Proinflammatory Cytokine
12%
Real-Time Polymerase Chain Reaction
12%
Downregulation
12%
Colon
12%
Autoimmune Disease
12%
Infliximab
12%
In Vitro
12%
Medicine and Dentistry
microRNA
100%
Tumor Necrosis
100%
Interleukin 17
100%
Inflammatory Bowel Disease
100%
T-Helper Cell
18%
Mucosa
18%
Cell Differentiation
18%
Peripheral Blood Mononuclear Cell
18%
Th17 Cell
18%
Antisense
12%
Colitis
12%
Lentivirus
12%
In Vitro
6%
Real-Time Polymerase Chain Reaction
6%
Downregulation
6%
Carcinogenesis
6%
Colon
6%
Inflammatory Cytokine
6%
Autoimmune Disease
6%
Infliximab
6%
Trinitrobenzenesulfonic Acid
6%
Trinitrobenzene Sulfonic Acid-Induced Colitis
6%